These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36338433)

  • 21. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
    Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
    Aicher SM; Streicher F; Chazal M; Planas D; Luo D; Buchrieser J; Nemcova M; Seidlova V; Zukal J; Serra-Cobo J; Pontier D; Pain B; Zimmer G; Schwartz O; Roingeard P; Pikula J; Dacheux L; Jouvenet N
    J Virol; 2022 Jul; 96(14):e0060822. PubMed ID: 35862713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
    Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
    J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.
    Zhou L; Xu Z; Castiglione GM; Soiberman US; Eberhart CG; Duh EJ
    bioRxiv; 2020 May; ():. PubMed ID: 32511393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Based Development of SARS-CoV-2 Spike Interactors.
    Squeglia F; Romano M; Esposito L; Barra G; Campiglia P; Sala M; Scala MC; Ruggiero A; Berisio R
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2.
    Tetz G; Tetz V
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
    Hekman RM; Hume AJ; Goel RK; Abo KM; Huang J; Blum BC; Werder RB; Suder EL; Paul I; Phanse S; Youssef A; Alysandratos KD; Padhorny D; Ojha S; Mora-Martin A; Kretov D; Ash PEA; Verma M; Zhao J; Patten JJ; Villacorta-Martin C; Bolzan D; Perea-Resa C; Bullitt E; Hinds A; Tilston-Lunel A; Varelas X; Farhangmehr S; Braunschweig U; Kwan JH; McComb M; Basu A; Saeed M; Perissi V; Burks EJ; Layne MD; Connor JH; Davey R; Cheng JX; Wolozin BL; Blencowe BJ; Wuchty S; Lyons SM; Kozakov D; Cifuentes D; Blower M; Kotton DN; Wilson AA; Mühlberger E; Emili A
    Mol Cell; 2021 Jan; 81(1):212. PubMed ID: 33417854
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant Rod Domain of Vimentin Reduces SARS-CoV-2 Viral Replication by Blocking Spike Protein-ACE2 Interactions.
    Lam FW; Brown CA; Ronca SE
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.
    Manfrini N; Notarbartolo S; Grifantini R; Pesce E
    Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.